Increased plasma-immune cytokines throughout the high-dose melphalan-induced lymphodepletion in patients with multiple myeloma: a window for adoptive immunotherapy.

Increased plasma-immune cytokines throughout the high-dose melphalan-induced lymphodepletion in patients with multiple myeloma: a window for adoptive immunotherapy.

Item
http://www.wikidata.org/entity/Q34079831
Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min MiceTransfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial.A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantationAlkylating agent melphalan augments the efficacy of adoptive immunotherapy using tumor-specific CD4+ T cellsBlockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myelomaProgrammed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma.Immunostimulatory Effects of Melphalan and Usefulness in Adoptive Cell Therapy with Antitumor CD4+ T Cells.Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.Not too little, not too much-just right! (Better ways to give high dose melphalan).Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastoma.Immunomodulatory effects of the Agaricus blazei Murrill-based mushroom extract AndoSan in patients with multiple myeloma undergoing high dose chemotherapy and autologous stem cell transplantation: a randomized, double blinded clinical studyAdjuvant IL-7 potentiates adoptive T cell therapy by amplifying and sustaining polyfunctional antitumor CD4+ T cellsExpansion of a restricted residual host T reg-cell repertoire is dependent on IL-2 following experimental autologous hematopoietic stem transplantation.
P2860

Increased plasma-immune cytokines throughout the high-dose melphalan-induced lymphodepletion in patients with multiple myeloma: a window for adoptive immunotherapy.

Item
http://www.wikidata.org/entity/Q34079831
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Increased plasma-immune cytoki ...... ow for adoptive immunotherapy.
@ast
Increased plasma-immune cytoki ...... ow for adoptive immunotherapy.
@en
Increased plasma-immune cytoki ...... ow for adoptive immunotherapy.
@nl
type
label
Increased plasma-immune cytoki ...... ow for adoptive immunotherapy.
@ast
Increased plasma-immune cytoki ...... ow for adoptive immunotherapy.
@en
Increased plasma-immune cytoki ...... ow for adoptive immunotherapy.
@nl
prefLabel
Increased plasma-immune cytoki ...... ow for adoptive immunotherapy.
@ast
Increased plasma-immune cytoki ...... ow for adoptive immunotherapy.
@en
Increased plasma-immune cytoki ...... ow for adoptive immunotherapy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Increased plasma-immune cytoki ...... ow for adoptive immunotherapy.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932